Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Amlexanox oral adhesive pellicles for minor recurrent aphthous ulcers
NL-OMON22280Active, not recruiting
- Sponsor
- Furikangzheng Medical Technology
- Start
- Mar 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial in aphthosis (RAS) comparing Amlexanox oral adhesive pellicles with Vehicle pellicles placebo (2 arms). Primary endpoints: Ulcer size reduction and Ulcer pain reduction. Started Mar 2005; status: active, not recruiting.
02
Drugs
amlexanox
03
Conditions
aphthosis (RAS)
Beyond the preview
Go deeper on NL-OMON22280.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON22280.